Medibrane Receives Investment and Debt Financing from Resonetics

Medibrane Ltd., a Tel Aviv, Israel-based company that designs, develops and manufactures customized polymeric coverings and coatings for medical frame-based applications, received an additional equity investment and debt financing from Resonetics.

The amount of the deal was not disclosed.

Resonetics first acquired a minority ownership in Medibrane as part of its November 2018 acquisition of STI Laser, also based in Israel.

Medibrane designs, develops, and manufactures customized polymeric biomaterial coverings and coatings for medical frame-based applications covering a diverse range of minimally invasive applications. They are used with nitinol frames in interventional procedures for structural heart, interventional cardiology, neurovascular and other minimally invasive procedures. The company is ISO 13485:2016 certified.

Founded in 1987, Resonetics is a pioneer in laser micro manufacturing and provides contract manufacturing services to the life sciences industry. The company designs, builds and services its own laser workstations to solve complex medical manufacturing challenges. Resonetics also manufactures thin-wall, stainless steel tubing, precious metal radiopaque marker bands and provides nitinol processing, as well as precision grinding, forming and machining of tight tolerance components and subassemblies for medical devices. The company is ISO 13485:2016 certified with facilities in the U.S., Costa Rica, Israel and Switzerland. It is owned by Regatta Medical, a portfolio company of GTCR, a private equity firm.



Join the discussion